Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol

MLA

Pozzi, F., et al. Clinical Applicability of PCASL as a Substitute for FDG-PET in the Etiological Diagnosis of MCI and SCD: CAPE Study Protocol. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1446972473&authtype=sso&custid=ns315887.

APA

Pozzi, F., Cerina, V., Licciardo, D., Guo, W., Brambilla, A., Cosentino, G., Remoli, G., Da Re, F., Conti, E., Tremolizzo, L., Moresco, R., Isella, V., De Bernardi, E., Morzenti, S., Musarra, M., Crivellaro, C., Appollonio, I., Ferrarese, C., Basso, G., … G. Basso. (2023). Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol.

Chicago

Pozzi, F, V Cerina, D Licciardo, W Guo, A Brambilla, G Cosentino, G Remoli, et al. 2023. “Clinical Applicability of PCASL as a Substitute for FDG-PET in the Etiological Diagnosis of MCI and SCD: CAPE Study Protocol.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1446972473&authtype=sso&custid=ns315887.